Rosiptor

DB13012InvestigationalSmall molecule

AQX-1125 has been used in trials studying the treatment of COPD, Atopic Dermatitis, Interstitial Cystitis, and Bladder Pain Syndrome.

Mechanism: Pharmacologically active on Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1
Curator reviewed
Formula / weight: C₂₀H₃₅NO₂ · 321.505 g/mol (avg)
Code names: AQX-1125

Resolves to

Compound

Structure

InChIKeyMDEJTPWQNNMAQF-BVMLLJBZSA-NSMILESC[C@]12CC[C@@H]([C@@H](CN)[C@@H]1CCC2=C)[C@@]1(C)CC[C@H](O)C[C@@H]1CO

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Rosiptor, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.